Obesity and chronic kidney disease


Cite item

Full Text

Abstract

Obesity and overweight are now characterized as epidemics. It is shown that body overweight is associated with functional and structural changes in the kidneys. The results of epidemiological studies indicate that obesity can be the risk factor of chronic kidney disease (CKD) irrespective of the presence or absence of diabetes, arterial hypertension and other comorbidities. Manifestations of renal pathology in obese persons include microalbuminuria and proteinuria, hyperfiltration or impaired renal function. Glomerulomegaly and focal segmental glomerulosclerosis are the most typical structural signs of obesity-related nephropathy. More evidence is accumulated on the link between CKD in obesity and abnormalities in adypokine secretion (hyperleptinemia, lack of adiponectin), activation of rennin-angiotensin system, chronic inflammation, endothelial dysfunction, lipid accumulation, impaired renal hemodynamics and diminished nephron number related to body mass. A decrease of body weight following lifestyle modification or bariatric surgery leads to reduction in albuminuria and eliminates hyperfiltration in obese subjects. Thus, prevention and treatment of obesity may reduce CKD incidence in general population.

About the authors

Irina Arkad'evna Bondar'

Email: diabet@oblmed.nsk.ru

Vadim Vladimirovich Klimontov

Email: klimontov@mail.ru

A I Simakova

I A Bondar

State Medical University, Novosibirsk

State Medical University, Novosibirsk

V V Klimontov

State Medical University, Novosibirsk

State Medical University, Novosibirsk

A I Simakova

State Medical University, Novosibirsk

State Medical University, Novosibirsk

References

  1. Дедов И. И., Мельниченко Г. А. (ред.). Ожирение. М.: Мед. информ. агентство; 2004.
  2. Hunley T. E., Ma L. J., Kon V. Scope and mechanisms of obesity-related renal diseasec Curr. Opin. Nephrol. Hypertens. 2010; 19 (3): 227-234.
  3. Федорова Е. Ю., Краснова Е. А., Шестакова М. В. Механизмы повреждения почек при ожирении. Ожирение и метаболизм 2006; 1: 22-28.
  4. Gelber R. P., Kurth T., Kausz A. T. et al. Association between body mass index and CKD in apparently healthy men. Am. J. Kidney Dis. 2005; 46 (5): 871-880.
  5. Ishizaka Y., Ishizaka N., Tani M. et al. Association between changes in obesity parameters and incidence of chronic kidney disease in Japanese individuals. Kidney Blood Press. Res. 2009; 32 (2): 141-149.
  6. Ryu S., Chang Y., Woo H. Y. Changes in body weight predict CKD in healthy men. J. Am. Soc. Nephrol. 2008; 19 (9): 1798-1805.
  7. Foster M. C., Hwang S. J., Larson M. G. et al. Association between body mass index and chronic kidney disease: a population-based, cross-sectional study of a Japanese community. Vasc. Hlth Risk Manag. 2009; 5 (1): 315-320.
  8. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am. J. Kidney Dis. 2008; 52 (1): 39-48.
  9. Kramer H., Luke A., Bidani A. et al. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am. J. Kidney Dis. 2005; 46 (4): 587-594.
  10. Munkhaugen J., Lydersen S., Wideré T. E., Hallan S. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway. Am. J. Kidney Dis. 2009; 54 (4): 638-646.
  11. Chen J., Muntner P., Hamm L. L. et al. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann. Intern. Med. 2004; 140 (3): 167-174.
  12. Chen J., Gu D., Chen C. S. et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol. Dial. Transplant. 2007; 22 (4): 1100-1106.
  13. Noori N., Hosseinpanah F., Nasiri A. A., Azizi F. Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J. Ren. Nutr. 2009; 19 (3): 228-237.
  14. Tanaka M., Yamada S., Iwasaki Y. et al. Impact of obesity on IgA nephropathy: comparative ultrastructural study between obese and non-obese patients. Nephron. Clin. Pract. 2009; 112 (2): c71-c78.
  15. Bonnet F., Deprele C., Sassolas A. et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am. J. Kidney Dis. 2001; 37 (4): 720-727.
  16. Lee M. N., Shaikh U., Butani L. Effect of overweight/obesity on recovery after post-infectious glomerulonephritis. Clin. Nephrol. 2009; 71 (6): 632-636.
  17. Савельева С. А., Крячкова А. А., Курумова К. О. и др. Ожирение-фактор риска поражения почек у больных сахарным диабетом 2-го типа. Сахар. диабет 2010; 2: 45-49.
  18. Othman M., Kawar B., El Nahas A. M. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Nephron. Clin. Pract. 2009; 113 (1): c16-c23.
  19. Postorino M., Marino C., Tripepi G. et al. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J. Am. Coll. Cardiol. 2009; 53 (15): 1265-1272.
  20. Chow W. H., Devesa S. S. Contemporary epidemiology of renal cell cancer. Cancer J. 2008; 14 (5): 288-301.
  21. Klinghoffer Z., Yang B., Kapoor A., Pinthus J. H. Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations. Expert. Rev. Anticancer. Ther. 2009; 9 (7): 975-987.
  22. Srivastava T. Nondiabetic consequences of obesity on kidney. Pediatr. Nephrol. 2006; 21 (4): 463-470.
  23. Kambham N., Markowitz G. S., Valeri A. M. et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001; 59 (4): 1498-1509.
  24. Adelman R. D., Restaino I. G., Alon U. S., Blowey D. L. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J. Pediatr. 2001; 138 (4): 481-485.
  25. Serra A., Romero R., Lopez D. et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008; 73 (8): 947-955.
  26. Goumenos D. S., Kawar B., El Nahas M. et al. Early histological changes in the kidney of people with morbid obesity. Nephrol. Dial. Transplant. 2009; 24 (12): 3732-3738.
  27. Chen H. M., Li S. J., Chen H. P. et al. Obesity-related glomerulopathy in China: a case series of 90 patients. Am. J. Kidney Dis. 2008; 52 (1): 58-65.
  28. Chen H. M., Liu Z. H., Zeng C. H. et al. Podocyte lesions in patients with obesity-related glomerulopathy. Am. J. Kidney Dis. 2006; 48 (5): 772-779.
  29. Verhave J. C., Fesler P., Ribstein J. et al. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am. J. Kidney Dis. 2005; 46 (2): 233-241.
  30. Demirovic J. A., Pai A. B., Pai M. P. Estimation of creatinine clearance in morbidly obese patients. Am. J. Hlth Syst. Pharm. 2009; 66 (7): 642-648.
  31. Сагинова Е. А., Галямов Н. Г., Северова Н. Н. Современные представления о поражении почек при ожирении. Клин. нефрол. 2010; 2: 66-71.
  32. Руденко Т. Е., Кутырина И. М. Ожирение как фактор сосудистого ремоделирования. Клин. нефрол. 2010; 3: 62-67.
  33. Ritz E., Kolgeganova T., Piecha G. Is there an obesity-metabolic syndrome related glomerulopathy? Curr. Opin. Nephrol. Hypertens. 2010; In press.
  34. Galic S., Oakhill J. S., Steinberg G. R. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 2010; 316 (2): 129-139.
  35. Zhang Y., Scarpace P. J. The role of leptin in leptin resistance and obesity. Physiol. Behav. 2006; 88 (3): 249-256.
  36. Nanayakkara P. W., Le Poole C. Y., Fouque D. et al. Plasma adi-ponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K/DOQI 3-5 chronic kidney disease. Clin. Nephrol. 2009; 72 (1): 21-30.
  37. Wolf G., Ziyadeh F. N. Leptin and renal fibrosis. Contrib. Nephrol. 2006; 151: 175-183.
  38. Wu Y., Liu Z., Xiang Z. et al. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 2006; 147 (1): 44-50.
  39. Sharma K., Ramachandrarao S., Qiu G. et al. Adiponectin regulates albuminuria and podocyte function in mice. J. Clin. Invest. 2008; 118 (5): 1645-1656.
  40. Ohashi K., Iwatani H., Kihara S. et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler. Thromb. Vase. Biol. 2007; 27 (9): 1910-1917.
  41. Praga M., Morales E. Obesity, proteinuria and progression of renal failure. Curr. Opin. Nephrol. Hypertens. 2006; 15 (5): 481-486.
  42. Chalmers L., Kaskel F. J., Bamgbola O. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Adv. Chron. Kidney Dis. 2006; 13 (4): 352-364.
  43. Кутырина И. М., Крячкова А. А., Савельева С. А., Шестакова М. В. Роль альдостерона в поражении почек при метаболическом синдроме, ассоциированном с ожирением. Клин, нефрол. 2010; 4: 34-38.
  44. Шварц В. Воспаление жировой ткани. Часть 1. Морфологические и функциональные проявления. Пробл. эндокринол. 2009; 4: 44-49.
  45. Шварц В. Воспаление жировой ткани. Часть 3. Патогенетическая роль в развитии атеросклероза. Пробл. эндокринол. 2009; 6: 40-45.
  46. Teplan V. Jr., Vyhnänek F., Gürlich R. et al. Increased proinflamma-tory cytokine production in adipose tissue of obese patients with chronic kidney disease. Wien. Klin. Wschr. 2010; 122 (15-16): 466-473.
  47. Ramos L. F., Shintani A., Ikizler T. A., Himmelfarb J. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J. Am. Soc. Nephrol. 2008; 19 (3): 593-599.
  48. Elmarakby A. A., Imig J. D. Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats. Clin. Sci. (Lond.) 2010; 118 (4): 291-301.
  49. Мухин Н. А., Фомин В. В., Сагинова Е. А. и др. Эндотелиальная дисфункция и поражение почек при ожирении. Вестн. РАМН 2006; 12: 25-31.
  50. Сагинова Е. А., Федорова Е. Ю., Фомин В. В. и др. Формирование поражения почек у больных ожирением. Тер. арх. 2006; 5: 36-41.
  51. Deji N., Kume S., Araki S. et al. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am. J. Physiol. Renal Physiol. 2009; 296 (1): F118-F126.
  52. Jiang T., Wang Z., Proctor G. et al. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J. Biol, Chem. 2005; 280 (37): 32317-32325.
  53. Bosma R. J., Krikken J. A., Homan van der Heide J. J. et al. Obesity and renal hemodynamics. Contrib. Nephrol. 2006; 151: 184-202.
  54. Кутырина И. М., Федорова Е. Ю., Шестакова М. В. Ожирение и почки. В кн.: Сахарный диабет и хроническая болезнь почек. М.: Мед. информ. Агентство; 2009. 415-428.
  55. Praga M., Hernandez E., Herrero J. C. et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000; 58 (5): 2111-2118.
  56. Gonzalez E., Gutierrez E., Morales E. et al. Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney. Kidney Int. 2005; 68 (1): 263-270.
  57. Navaneethan S. D., Yehnert H., Moustarah F. et al. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 2009; 4 (10): 1565-1574.
  58. Ishizaka Y., Ishizaka N., Tani M. et al. Association between changes in obesity parameters and incidence of chronic kidney disease in Japanese individuals. Kidney Blood Press. Res. 2009; 32 (2): 141-149.
  59. Shen W. W., Chen H. M., Chen H. et al. Obesity-related glomerulopa-thy: body mass index and proteinuria. Clin. J. Am. Soc. Nephrol. 2010; 5 (8): 1401-1409.
  60. Chagnac A., WeinsteinT., Herman M. et al. The effects of weight loss on renal function in patients with severe obesity. J. Am. Soc. Nephrol. 2003; 14 (6): 1480-1486.
  61. Navarro-Diaz M., Serra A., Romero R. et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J. Am. Soc. Nephrol. 2006; 17 (12, Suppl. 3): S213-S217.
  62. Serpa Neto A., Bianco Rossi F. M., Dal Moro Amarante R. et al. Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients. J. Nephrol. 2009; 22 (5): 637-646.
  63. Huan Y., Tomaszewski J. E., Cohen D. L. Resolution of nephrotic syndrome after successful bariatric surgery in patient with biopsy-proven FSGS. Clin. Nephrol. 2009; 71 (1): 69-73.
  64. Недогора С. В. Возможности нефропротекции у пациентов с метаболическим синдромом. Клин. нефрол. 2009; 2: 26-30.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies